General Hospital Djordje Jovanovic Zrenjanin
About General Hospital Djordje Jovanovic Zrenjanin
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
5
CENTOGENE GmbH Rostock
1
Fresenius Kabi SwissBioSim GmbH
1
InDex Pharmaceuticals
1
Clinical Trials at General Hospital Djordje Jovanovic Zrenjanin
During the past decade, General Hospital Djordje Jovanovic Zrenjanin conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 2 clinical trials were completed, i.e. on
average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP)
2016-12-01
2022-05-27
Completed
500
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
2015-12-02
2025-02-27
Active, not recruiting
878
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2018-03-07
2024-06-28
Recruiting
600
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2018-06-27
2025-06-24
Recruiting
485
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
2018-08-24
2029-12-27
Recruiting
1,200
MSB11456 in Participants With Moderately to Severely Active Rheumatoid Arthritis
2020-08-03
2022-06-06
Completed
604
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
2021-11-24
2024-12-31
Recruiting
440
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at General Hospital Djordje Jovanovic Zrenjanin
According to Clinical.Site data, the most researched conditions in "General Hospital Djordje Jovanovic Zrenjanin" are
"Crohn Disease" (3 trials), "Ulcerative Colitis" (3 trials), "Cardiac Failure" (1 trials), "Gastrointestinal Disorders" (1 trials) and "Neuropathic Pain" (1 trials). Many other conditions were trialed in "General Hospital Djordje Jovanovic Zrenjanin" in a lesser frequency.
Clinical Trials Intervention Types at General Hospital Djordje Jovanovic Zrenjanin
Most popular intervention types in "General Hospital Djordje Jovanovic Zrenjanin" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Ozanimod" (3 trials), "RPC1063" (2 trials), "Cobitolimod 250 mg" (1 trials) and "Cobitolimod 500 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at General Hospital Djordje Jovanovic Zrenjanin
The vast majority of trials in "General Hospital Djordje Jovanovic Zrenjanin" are
8 trials for "All" genders.
Clinical Trials Status at General Hospital Djordje Jovanovic Zrenjanin
Currently, there are NaN active trials in "General Hospital Djordje Jovanovic Zrenjanin".
undefined are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in General Hospital Djordje Jovanovic Zrenjanin,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in General Hospital Djordje Jovanovic Zrenjanin, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".